Stent for angioplasty and a production process therefor

Details Stent for angioplasty and a production process therefor Stent for angioplasty and a production process therefor

1998-01-08

2003-11-11

McDermott, Corrine (Department: 3738)

Prosthesis (i.e., artificial body members), parts thereof, or ai

Arterial prosthesis

Having plural layers

C623S001150, C623S001440, C600S003000

Reexamination Certificate

active

06645243

ABSTRACT:

FIELD OF THE INVENTION
The present invention generally concerns so-called stents for angioplasty.
BACKGROUND OF THE INVENTION
The term “stent” is intended generally to indicate devices intended for endoluminal application (for example, within a blood vessel) usually effected by catheterisation, with the subsequent expansion in place for the local support of the lumen. The principal aim of this is to avoid the re-establishment of a stenotic site at the treated site. It should be noted that the use of substantially similar structures to effect the expansion and anchorage in place of vascular grafts has already been proposed in the art: naturally, this possible extension of the field of application should also be seen as being included within the ambit of the invention.
For a general review of vascular stents, reference may usefully be made to the work “Textbook of Interventional Cardiology” edited by Eric J. Topol, W. B. Saunders Company, 1994 and, in particular, to section IV of volume II, entitled “Coronary stenting”.
Many patent documents have addressed this problem, such as, for example, U.S. Pat. No. 4,776,337, U.S. Pat. No. 4,800,882, U.S. Pat. No. 4,907,336, U.S. Pat. No. 4,886,062, U.S. Pat. No. 4,830,003, U.S. Pat. No. 4,856,516, U.S. Pat. No. 4,768,507, and U.S. Pat. No. 4,503,569.
One problem that is not yet completely resolved in connection with the implantation of a stent is in relation to restenosis which, depending on the type of lumen in question, may be more or less likely to occur. Several studies have shown that the principal mechanism causing restenosis after the stent-implantation operation is a hyperplasia of the neointima mediated by the cells of the smooth muscle.
It has, however, been noted that nuclear radiation, in particular &bgr;-radiation, inhibits the formation of the neointima. The manufacture of a stent capable of emitting nuclear radiation has therefore already been proposed: in this way, after implantation, the surrounding tissues become irradiated, which inhibits the above-mentioned hyperplasia.
To this end, atoms of the P
32
radionuclide are injected, by means of a cyclotron, onto the surface of a stent made from conventional material, for example, stainless steel, before it is implanted (see “Radioactive Stents for the Prevention of Neointimal Hyperplasia” by Tim A. Fischell, from “Endoluminal Stenting” chapter 18, p. 134 (1996) edited by W. B. Saunders Company Ltd).
According to a similar technique (see “Technical and Engineering Aspects of Stents Which May Be Either Permanent or Removable” by R. Makkar et al., from “Endoluminal Stenting”, chapter 32, p. 230, (1996) edited by W. B. Saunders Company Ltd), a titanium stent is bombarded with protons having an energy equal to 8 MeV, which provoke the reaction Ti
48
(p,n)V
48
, also leading in this case to the formation of a radioactive nuclide.
These methods require the use of very complicated equipment, such as a cyclotron, for accelerating the charged particles. In addition, since these particles are retained on the surface layer of the stent body, a sophisticated system must be provided for moving the latter in order to expose as much as possible of its surface to the particle beam.
Overall, therefore, these known techniques, although valid for research, are not suited to the mass production of radioactive stents.
SUMMARY OF THE INVENTION
The object of the present invention is that of overcoming the aforesaid disadvantages, and the invention has the characteristics referred to specifically in the claims.
In one aspect, the invention is a stent for angioplasty having a body in the form of a generally tubular casing capable of being dilated in use from a radially-contracted position to a radially-expanded position, the body comprising a support structure of a first material capable of withstanding dilation without losing its structural integrity, and having associated with at least a part of the support structure a structure made from a second material which is made radioactive following the exposure of the stent to a neutron flux.
The structure made from the second material may comprise a continuous layer on at least a portion of the support structure or on the entire support structure. The continuous layer may range in thickness between 0.4 and 1 micrometer.
In a preferred embodiment, the structure made from the second material forms a core within the support structure. The core may have a diameter of between 10 and 100 micrometers.
In another preferred embodiment, the structure made from the second material is in the form of a plurality of inserts housed in associated recesses formed on the surface of the support structure.
The second material may be iridium, tantalum or mixtures thereof.
In another aspect, this invention is a method for the production of a stent having a body in the form of a generally tubular casing capable of being dilated in use from a radially-contracted position to a radially-expanded position, the body comprising a support structure of a first material capable of withstanding dilation without losing its structural integrity, and having associated with at least a part of the support structure a structure made from a second material which is radioactivatable, wherein the body is exposed to a neutron flux so as to render the second material radioactive.
The body may further comprise a carbon film.
The association of the second structure with the support structure may be achieved by means of galvanic techniques or sputtering, by coextrusion, or by welding, mounting or inclusion.
In yet another aspect, this invention is an intermediate product obtainable by the method for the production of a stent having a body in the form of a generally tubular casing capable of being dilated in use from a radially-contracted position to a radially-expanded position, the body comprising a support structure of a first material capable of withstanding dilation without losing its structural integrity, and having associated with at least a part of the support structure a structure made from a second material which is radioactivatable, wherein the body is exposed to a neutron flux so as to render the second material radioactive.


REFERENCES:
patent: 4349498 (1982-09-01), Ellis et al.
patent: 4503569 (1985-03-01), Dotter
patent: 4768507 (1988-09-01), Fischell et al.
patent: 4776337 (1988-10-01), Palmaz
patent: 4800882 (1989-01-01), Gianturco
patent: 4830003 (1989-05-01), Wolff et al.
patent: 4856516 (1989-08-01), Hillstead
patent: 4886062 (1989-12-01), Wiktor
patent: 4907336 (1990-03-01), Gianturco
patent: 5059166 (1991-10-01), Fischell et al.
patent: 5342283 (1994-08-01), Good
patent: 5449373 (1995-09-01), Pinchasik et al.
patent: 5632771 (1997-05-01), Boatman et al.
patent: 5707332 (1998-01-01), Weinberger
patent: 5713828 (1998-02-01), Coniglione
patent: 5871437 (1999-02-01), Alt
patent: 5891191 (1999-04-01), Stinson
patent: 6146322 (2000-11-01), Papirov et al.
patent: 6159142 (2000-12-01), Alt
patent: 6419621 (2002-07-01), Sioshansi et al.
patent: 0433011 (1991-06-01), None
patent: 0 540 290 (1992-10-01), None
patent: WO 96/03092 (1996-02-01), None
T. A. Fischell, “Radioactive Stents for the Prevention of Neointimal Hyperplasia”,Physician's Press “The new manual of interventional cardiology”, chapter 18, p. 134 ss (1996).
R. Makkar et al., “Technical and Engineering Aspects of Stents Which May be Either Permanent or Removable”,Endoluminal Stenting, chapter 32, p. 230 (1996).
E. J. Topel, (ed.), “Coronary Stenting”,Textbook of Interventional Cardiology, Sec. IV of vol. 11 (1994).

Affiliated with

Also associated with

Rating

Stent for angioplasty and a production process therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stent for angioplasty and a production process therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent for angioplasty and a production process therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3125716